Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Gloved hand holding test tube with alpha-synuclein on label

    Safety Results from Potential Parkinson's Drug Prompt $1.4 Million Grant from Michael J. Fox Foundation

    A drug against alpha-synuclein was safe and tolerable in control volunteers, leading our Foundation to invest nearly $1.4 million for testing in people with Parkinson’s disease.
    Learn more
  • Doctor Equipment

    News in Context: LRRK2 Therapies Speeding Forward after $1B Biotech Deal

    This partnership speeding therapeutic testing is built on work from The Michael J. Fox Foundation de-risking LRRK2 drug development and supporting measurement tools.
    Learn more
  • On Laptop

    Don’t Miss MJFF’s New Webinar Series on Parkinson’s R&D

    Thanks to all of you — our moderators, panelists, viewers and sponsors — the new Parkinson's Disease Therapeutics Webinars series is already a success.
    Learn more
  • Ken Griffin Alpha-Synuclein Imaging Competition

    Three Teams Win the “Ken Griffin Alpha-synuclein Imaging Competition”  

    Three teams will pursue unique approaches to develop this game-changing research tool.
    Learn more
  • PET-CT.jpg

    Research Perspective: Alpha-Synuclein Imaging

    Over the last 10 years, researchers have made impressive strides in the development of an alpha-synuclein imaging agent.
    Learn more
  • Default content image

    News in Context: Progress of “Long Sought Blood Test for Alzheimer’s”

    The New York Times reports a blood test for the protein tau may help identify people with Alzheimer’s even before symptoms arise.
    Learn more
  • First Drug Approved for Dyskinesia in Parkinson's Disease

    Dyskinesia Drug Gocovri Also May Decrease “Off” Time

    New research suggests Gocovri, approved to treat dyskinesia (involuntary movement), also may lessen “off” time — when Parkinson’s symptoms are not controlled.
    Learn more
Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD CEO
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Join Our Email List
Stay up to date with the latest research and news from The Michael J. Fox Foundation.